Efficacy, safety, and cost-effectiveness of triple therapy in preventing relapse in rheumatoid arthritis: A randomized controlled trial (ESCoRT study)

BACKGROUND: Biological agents, such as tumor necrosis factor inhibitors (TNFi), have been widely used in rheumatoid arthritis (RA) patients and greatly improved goal achievement. The aim of this study was to investigate whether conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Juan, Zhou, Wei, Wu, Yangfeng, Yan, Xiaoyan, Yang, Li, Zhang, Zhuoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771172/
https://www.ncbi.nlm.nih.gov/pubmed/36525606
http://dx.doi.org/10.1097/CM9.0000000000002336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771172/
https://www.ncbi.nlm.nih.gov/pubmed/36525606
http://dx.doi.org/10.1097/CM9.0000000000002336

Ejemplares similares